Roger Franklin

Partner

Roger Franklin is a Partner at Hadean Ventures, a European life science venture capital firm with offices in Oslo and Stockholm.1 3 Here are some key details about his background and role:

Professional Experience

Roger Franklin joined Hadean Ventures as a Partner in November 2018.1 4 He has over a decade of experience in the life science industry, spanning various senior roles in venture capital, investment banking, and strategy consulting.1 2

Education and Expertise

PhD in oncology from the University of Cambridge2
Completed academic training in biochemistry at Oxford University1
Specializes in oncology, with a particular focus on therapeutics opportunities1 2

Current Role and Responsibilities

As a Partner at Hadean Ventures, Roger:

Is based in the Stockholm office at the Karolinska Institute Science Park1
Focuses on therapeutics opportunities and life science investments across Europe, with a particular emphasis on the Nordic region1 3
Brings significant experience in venture and public market transactions1
Contributes scientific, technical, and operational expertise to the firm1

Board Positions

Roger Franklin holds several board positions, including:

Board Director of Abliva AB (Sweden)2 5
Board Director of TargED Biopharmaceuticals BV (Netherlands)2 5
Board Director of Gesynta Pharma AB5

He also serves as a Board Observer for multiple companies, including Pipeline Therapeutics Inc, Step Pharma SAS, Emergence Therapeutics AG, and Cardior Pharmaceuticals GmbH.2

Roger Franklin's extensive experience in life sciences, combined with his strong scientific background and strategic expertise, makes him a valuable asset to Hadean Ventures and its portfolio companies.1 6